Ipratropium Bromide And Albuterol Sulfate Solution
NDC Package 69097-173-64

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Ipratropium Bromide And Albuterol Sulfate solution is ipratropium Bromide and Albuterol Sulfate Inhalation Solution is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator. This formulation utilizes a solution delivery system. Marketed by Cipla Usa Inc., this product is identified by NDC 69097-173 and is authorized under FDA application ANDA077559.

Identification & Billing

NDC Package Code
69097-173-64
Package Description
12 POUCH in 1 CARTON / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL
Product Code
69097-173
11-Digit Billing Format
69097017364
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 1437702 - ipratropium Br 0.5 MG / albuterol sulfate 3 MG in 3 ML Inhalation Solution
  • RxCUI: 1437702 - albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution
  • RxCUI: 1437702 - albuterol 2.5 MG (as albuterol sulfate 3 MG) / ipratropium bromide 0.5 MG per 3 ML Inhalation Solution

Clinical Specifications

Proprietary Name
Ipratropium Bromide And Albuterol Sulfate
Non-Proprietary Name
Ipratropium Bromide And Albuterol Sulfate
Substance Name
Albuterol Sulfate; Ipratropium Bromide
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator.

Regulatory & Marketing

Labeler Name
Cipla Usa Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA077559
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-31-2007
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J7620
Source: ASP
Albuterol ipratrop non-comp
HCPCS Dosage 2.5 MG/0.5 MG
Units / Pkg 60

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69097-173). Click a package code to view its specific billing and regulatory data.

69097-173-53
6 POUCH in 1 CARTON / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69097-173-64 identifies a specific commercial package of 12 pouch in 1 carton / 5 vial in 1 pouch / 3 ml in 1 vial of Ipratropium Bromide And Albuterol Sulfate, a human prescription drug labeled by Cipla Usa Inc.. This solution is formulated for respiratory (inhalation) use and contains albuterol sulfate; ipratropium bromide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cipla Usa Inc. on December 31, 2007. The current certification is valid through December 31, 2026.

How is this Cipla Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69097017364. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69097-173-64
11-Digit CMS (5-4-2)
69097-0173-64

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.